Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis

被引:71
作者
Abraham, Jerrold L. [1 ]
Thakral, Charu [1 ]
机构
[1] Upstate Med Univ, SUNY Albany, Dept Pathol, Syracuse, NY 13210 USA
关键词
gadolinium; transmetallation; biodistribution; toxicology; scanning electron microscopy; tissue microanalysis;
D O I
10.1016/j.ejrad.2008.01.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gadolinium (Gd) released from Gd-based MR contrast agents is the likely etiologic agent of nephrogenic systemic fibrosis (NSF). The biodistribution and kinetics of both chelated Gd and free Gd3+ are reviewed, including demonstrations of Gd in tissues of NSF patients. The purpose of this review is to consolidate the available information on distribution, metabolism, excretion and retention of Gd with particular emphasis on the possible mechanisms in the development of NSF. We also raise serious concern about the growing tissue burden of Gd with the release of Gd from its chelates and its yet unknown consequences. The development of NSF as well as potential long-term consequences of tissue Gd retention represent a part of the spectrum of Gd toxicity. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 50 条
  • [41] Nephrogenic systemic fibrosis
    Vosshenrich, R.
    Reimer, P.
    VASA-JOURNAL OF VASCULAR DISEASES, 2009, 38 (01): : 31 - 38
  • [42] Nephrogenic Systemic Fibrosis
    Weinreb, Jeffrey C.
    Kuo, Philip H.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2009, 17 (01) : 159 - +
  • [43] Nephrogenic systemic fibrosis
    Diego R. Martin
    Pediatric Radiology, 2008, 38 : 125 - 129
  • [44] Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent
    Clorius, S.
    Technau, K.
    Watter, T.
    Schwertfeger, E.
    Fischer, K.-G.
    Walz, G.
    Gerke, P.
    CLINICAL NEPHROLOGY, 2007, 68 (04) : 249 - 252
  • [45] Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium-1997-2006-2016. Part 1
    Thomsen, Henrik S.
    ACTA RADIOLOGICA, 2016, 57 (05) : 515 - 520
  • [46] The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis
    Hashemi, Pantea
    Sina, Bahram
    Rietkerk, William
    Safai, Bijan
    JOURNAL OF NEPHROLOGY, 2013, 26 (01) : 48 - 54
  • [47] Effects of Gadolinium Contrast Agents in Naive and Nephrectomized Rats: Relevance to Nephrogenic Systemic Fibrosis
    Grant, D.
    Johnsen, H.
    Juelsrud, A.
    Lovhaug, D.
    ACTA RADIOLOGICA, 2009, 50 (02) : 156 - 169
  • [48] Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis
    Perazella, Mark A.
    CURRENT DRUG SAFETY, 2008, 3 (01) : 67 - 75
  • [49] A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh, M.
    Davenport, A.
    Clatworthy, I.
    Lewin, J.
    Deroide, F.
    Hubbard, V.
    Rustin, M. H. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (06) : 1358 - 1362
  • [50] Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis
    Varela U, Cristian
    Carlos Prieto-Ray, Juan
    REVISTA MEDICA DE CHILE, 2014, 142 (12) : 1565 - 1574